Related Experiment Video
Updated: Jan 22, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
An update on the modern management of paediatric uveitis
Jessy Choi1, Daniel P Hawley2, Jane Ashworth3
1Department of Ophthalmology, Sheffield Children's Hospital, Sheffield, UK jessy.choi@nhs.net.
Insights
Pediatric uveitis, often silent and blinding in children, requires early diagnosis and multidisciplinary management. Prompt treatment of this eye inflammation improves long-term visual outcomes.
Area of Science:
- Ophthalmology
- Pediatrics
- Rheumatology
Background:
- Pediatric uveitis (PU) is a chronic, often asymptomatic inflammatory eye condition in children and young people (CYP).
- It can lead to severe ocular complications like band keratopathy and cataracts, resulting in permanent vision loss.
- PU is frequently associated with systemic diseases, notably juvenile idiopathic arthritis, with a 5-year cumulative incidence of 10-14%.
Purpose of the Study:
- To highlight evidence-based practices for managing pediatric uveitis.
- To raise awareness among various medical specialists about early detection and intervention for PU.
- To emphasize the need for multidisciplinary care and early systemic treatment to achieve disease inactivity and improve long-term outcomes.
Main Methods:
- Review of current literature and evidence-based guidelines for pediatric uveitis management.
- Discussion of diagnostic challenges and therapeutic approaches specific to pediatric populations.
- Emphasis on a coordinated, multidisciplinary approach involving pediatric ophthalmologists, rheumatologists, and other healthcare professionals.
Main Results:
- Pediatric uveitis presents unique challenges compared to adult-onset forms, often requiring prolonged screening and management.
- Inadequate control of inflammation can lead to irreversible structural damage and vision impairment.
- Early and complete disease inactivity is crucial for favorable long-term visual prognosis.
Conclusions:
- Optimal management of pediatric uveitis necessitates a collaborative, multidisciplinary strategy.
- Early systemic treatment and vigilant monitoring are key to preventing sight-threatening complications.
- Raising awareness across specialties is vital for timely diagnosis and intervention in CYP with uveitis.
Abstract:
Uveitis in children and young people (CYP) is often painless, chronic and persistent. It is an often silent blinding condition. Uveitis can be isolated or develop as a manifestation of a systemic disease. Due to the symptomless nature, it can present late with advanced ocular comorbidities such as band keratopathy, hypotony, cataracts. Inadequate control of the eye inflammation can result in permanent and severe ocular complications, structural damage and visual loss. One of the most common systemic associations is juvenile idiopathic arthritis where uveitis has a cumulative incidence of approximately 10%-14% (though wide variation in incidence is reported) after 5 years. Appropriately targeted uveitis screening is recommended to continue for at least 7 years in some subgroups. Paediatric uveitis poses multiple diagnostic and therapeutic challenges. Clinical manifestation and disease course may differ significantly from adult-onset uveitis. However, some CYP are still managed by adult specialists alone, without the opportunity for the prompt use of National Health Service England approved therapy. Optimal management of paediatric uveitis requires a multidisciplinary approach involving coordinated working of different specialities and healthcare professionals. This article highlights the evidence-based practice for the contemporary management of paediatric uveitis to readers in different specialities who may come across this condition. It raises awareness of early systemic treatment aiming to achieve early and complete disease inactivity thereby improving the chances of a long-term positive outcome.
More Related Videos
Related Concept Videos
Modern Molecular Taxonomy
Impression Management Techniques I: Managing Appearances
Tonsillitis II: Management
Management of Insomnia
Managing Impressions
Cystic Fibrosis: Management
Sinus disease and chronic...

